| EUROAPI

Our visin

Reinventing active ingredient solutions to sustainably meet clients’ and patients’ needs around the world.

Our Offer

With approximately €1 billion in sales in 2023, EUROAPI ranks #1 in small molecules APIs, and our strong innovation and R&D capabilities allow us to accelerate our development in more complex molecule segments through CDMO activities.

At approximately 200 APIs, EUROAPI offers one of the largest portfolios in the industry, addressing a wide variety of patients and providing coverage for more than 80 countries.

We provide expertise in Quality, Regulatory and Supply and have dedicated commercial teams for our clients around the globe.

CDMO services

Expert tailor-made partnerships for innovative companies

Learn more

API Solutions

Approximately 200 APIs available for human & animal health

Learn more

Industrial network

A global industrial network at your service

Learn more

Our fundamentals

We are driven by the success of our clients and their satisfaction

Reliability

EUROAPI is the leading small molecules API player with an unique European industrial platform and proven track record for reliability.
Quality

EUROAPI provides you with active ingredients that meet the highest pharmaceutical standards.
Premium Client Service

EUROAPI manufactures your success through tailored solutions and a long-term partnership approach that provides peace of mind.

A pharmacist giving a medicine to a client

Who We Are, What We Do

6

Production Sites based in Europe
Learn more
~200

API Solutions
Learn more
~3,650

Employees
Learn more

A dedicated
Contract Development Manufacturing Organization team

CDMO

Learn more

Our Commercial Network is covering 80 cOuntries and our 6 industrial sites are located in Europe

Together to improve

Quality and regulatory cOmpliance

GMP & GDP compliance.
High quality level throughout the manufacturing chain including raw material sourcing.
Strong track record with health authorities.

Download